IRD · Opus Genetics, Inc.
$3.78
+0.07 (+1.89%)
At close · Aug 3
Market Cap
$301.98M
Shares
81.40M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dr. George Magrath | CEO | $1,493,383 |
| Dr. Ashwath Jayagopal | Chief Scientific and Development Officer | $764,848 |
| Joseph Schachle | COO | $718,408 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Ashwath Jayagopal | Chief Scientific and Development Officer | $1,242,154 |
| Dr. George Magrath | CEO | $889,238 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | CEO | $2,811,138 |
| Dr. George Magrath | CEO | $2,667,353 |
| Richard Rodgers | CEO | $899,076 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $789,918 |
| Amy Rabourn | Head of Financial Quality Assurance | $789,918 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | CEO | $1,341,595 |
| Amy Rabourn | Head of Financial Quality Assurance | $499,267 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $446,496 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mina Sooch | CEO | $801,030 |
| Amy Rabourn | Head of Financial Quality Assurance | $332,093 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $325,094 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Douglas J. Swirsky | CEO | $1,572,528 |
| Mina Sooch | CEO | $486,887 |
| Amy Rabourn | Head of Financial Quality Assurance | $266,656 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $104,179 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Douglas J. Swirsky | CEO | $650,677 |
| Amy Rabourn | Head of Financial Quality Assurance | — |
| Mina Sooch | CEO | — |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Gagnon | principal accounting officer | Appointed | 2025-09-02 |
| Robert Gagnon | Chief Financial Officer | Appointed | 2025-09-02 |
| Nirav Jhaveri | Chief Financial Officer | Terminated | 2025-06-25 |
Key facts
CIK
1228627
CUSIP
67577R102
13F (30d)
14 filings
14 filers
Visit website
Investor relations